191 related articles for article (PubMed ID: 25034059)
21. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?
Poldermans D; Bax JJ; Schouten O; Neskovic AN; Paelinck B; Rocci G; van Dortmont L; Durazzo AE; van de Ven LL; van Sambeek MR; Kertai MD; Boersma E;
J Am Coll Cardiol; 2006 Sep; 48(5):964-9. PubMed ID: 16949487
[TBL] [Abstract][Full Text] [Related]
22. High-dose beta-blockers and tight heart rate control reduce myocardial ischemia and troponin T release in vascular surgery patients.
Feringa HH; Bax JJ; Boersma E; Kertai MD; Meij SH; Galal W; Schouten O; Thomson IR; Klootwijk P; van Sambeek MR; Klein J; Poldermans D
Circulation; 2006 Jul; 114(1 Suppl):I344-9. PubMed ID: 16820598
[TBL] [Abstract][Full Text] [Related]
23. Determinants of recurrent ventricular arrhythmia or death in 300 consecutive patients with ischemic heart disease who experienced aborted sudden death: data from the Leiden out-of-hospital cardiac arrest study.
Kiès P; Boersma E; Bax JJ; van der Burg AE; Bootsma M; van Erven L; van der Wall EE; Schalij MJ
J Cardiovasc Electrophysiol; 2005 Oct; 16(10):1049-56. PubMed ID: 16191114
[TBL] [Abstract][Full Text] [Related]
24. Does beta-blocker therapy improve clinical outcomes of acute myocardial infarction after successful primary angioplasty?
Kernis SJ; Harjai KJ; Stone GW; Grines LL; Boura JA; O'Neill WW; Grines CL
J Am Coll Cardiol; 2004 May; 43(10):1773-9. PubMed ID: 15145098
[TBL] [Abstract][Full Text] [Related]
25. Predicting maximum heart rate among patients with coronary heart disease receiving beta-adrenergic blockade therapy.
Brawner CA; Ehrman JK; Schairer JR; Cao JJ; Keteyian SJ
Am Heart J; 2004 Nov; 148(5):910-4. PubMed ID: 15523326
[TBL] [Abstract][Full Text] [Related]
26. Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Disease).
White HD; Tonkin A; Simes J; Stewart R; Mann K; Thompson P; Colquhoun D; West M; Nestel P; Sullivan D; Keech AC; Hunt D; Blankenberg S;
J Am Coll Cardiol; 2014 Feb; 63(4):345-54. PubMed ID: 24140630
[TBL] [Abstract][Full Text] [Related]
27. Inadequate heart rate control despite widespread use of beta-blockers in outpatients with stable CAD: findings from the international prospective CLARIFY registry.
Tendera M; Fox K; Ferrari R; Ford I; Greenlaw N; Abergel H; Macarie C; Tardif JC; Vardas P; Zamorano J; Gabriel Steg P;
Int J Cardiol; 2014 Sep; 176(1):119-24. PubMed ID: 25042656
[TBL] [Abstract][Full Text] [Related]
28. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
29. New developments in the preoperative evaluation and perioperative management of coronary artery disease in patients undergoing vascular surgery.
Bauer SM; Cayne NS; Veith FJ
J Vasc Surg; 2010 Jan; 51(1):242-51. PubMed ID: 19954922
[TBL] [Abstract][Full Text] [Related]
30. Is plasma renin activity a biomarker for the prediction of renal and cardiovascular outcomes in treated hypertensive patients? Observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Sever PS; Chang CL; Prescott MF; Gupta A; Poulter NR; Whitehouse A; Scanlon M
Eur Heart J; 2012 Dec; 33(23):2970-9. PubMed ID: 22942337
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
Califf RM; Lokhnygina Y; Velazquez EJ; McMurray JJ; Leimberger JD; Lewis EF; Diaz R; Murin J; Pfeffer MA
Am J Cardiol; 2009 Jul; 104(2):151-7. PubMed ID: 19576338
[TBL] [Abstract][Full Text] [Related]
32. Impact of an acute coronary syndrome pathway in achieving target heart rate and utilization of evidence-based doses of beta-blockers.
Irani F; Herial N; Colyer WR
Am J Ther; 2012 Nov; 19(6):397-402. PubMed ID: 21317621
[TBL] [Abstract][Full Text] [Related]
33. Risk factors for coronary heart disease and survival after myocardial infarction.
Nauta ST; Deckers JW; van der Boon RM; Akkerhuis KM; van Domburg RT
Eur J Prev Cardiol; 2014 May; 21(5):576-83. PubMed ID: 22977276
[TBL] [Abstract][Full Text] [Related]
34. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
35. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
Haddad H; Searles G; Gillis A
Can J Cardiol; 2001 Feb; 17(2):179-83. PubMed ID: 11223488
[TBL] [Abstract][Full Text] [Related]
36. Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias.
Hirsch A; Windhausen F; Tijssen JG; Oude Ophuis AJ; van der Giessen WJ; van der Zee PM; Cornel JH; Verheugt FW; de Winter RJ;
Eur Heart J; 2009 Mar; 30(6):645-54. PubMed ID: 18824461
[TBL] [Abstract][Full Text] [Related]
37. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
Chan JD; Rea TD; Smith NL; Siscovick D; Heckbert SR; Lumley T; Chaves P; Furberg CD; Kuller L; Psaty BM
Am Heart J; 2005 Sep; 150(3):464-70. PubMed ID: 16169325
[TBL] [Abstract][Full Text] [Related]
38. Heart failure in acute myocardial infarction: a comparison between patients with or without heart failure criteria from the FAST-MI registry.
Juillière Y; Cambou JP; Bataille V; Mulak G; Galinier M; Gibelin P; Benamer H; Bouvaist H; Méneveau N; Tabone X; Simon T; Danchin N;
Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):326-33. PubMed ID: 22357361
[TBL] [Abstract][Full Text] [Related]
39. Beta-blockers and cardiovascular outcomes in dialysis patients: a cohort study in Ontario, Canada.
Kitchlu A; Clemens K; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Manno M; Oliver MJ; Quinn RR; Suri RS; Wald R; Yan AT; Garg AX
Nephrol Dial Transplant; 2012 Apr; 27(4):1591-8. PubMed ID: 21873621
[TBL] [Abstract][Full Text] [Related]
40. β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study.
Sorbets E; Steg PG; Young R; Danchin N; Greenlaw N; Ford I; Tendera M; Ferrari R; Merkely B; Parkhomenko A; Reid C; Tardif JC; Fox KM;
Eur Heart J; 2019 May; 40(18):1399-1407. PubMed ID: 30590529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
